Helicobacter pylori infection is associated with a higher risk for type 2 diabetes developing.
Sustained increase in physical activity, decrease in sedentary time seen with behavioral intervention.
In postmenopausal women, low optimism, high negative emotional expressiveness, and hostility are associated with an increased risk for type 2 diabetes.
Higher consumption of nuts, especially tree nuts, is associated with reduced cardiovascular disease incidence and mortality among patients with type 2 diabetes.
The AACE and ACE published an annual update to their joint type 2 diabetes management algorithm.
PCOS one of most influential predictors of T2DM after adjustment for BMI, education, family history.
Albiglutide is available in other countries, and this trial may serve as an impetus for its reintroduction in the United States, particularly if follow-up results show a survival advantage with albiglutide.
Maternal glycemia during pregnancy may influence childhood glucose and insulin resistance regardless of BMI and family history of diabetes.
Recommendations suggest doctors prescribe individualized exercise training for these patients.
Fracture risk up with T2DM and current use of rosiglitazone, pioglitazone regardless of glycemic control.
Patients with type 2 diabetes treated with liraglutide experience a greater reduction in systolic BP if they have lower baseline continuous glucose monitoring values and higher diastolic BP.
The ADA published its 2019 Standards of Medical Care in Diabetes, an evidence-based document intended to provide clinicians, patients, and other stakeholders in the diabetes treatment landscape with up-to-date recommendations.
Prevalence of active migraine decreased linearly in the 24 years prior to diabetes diagnosis.
Patients with stable type 2 diabetes may be unnecessarily self-monitoring blood glucose levels despite this practice being recognized as a low-value service.
Brain atrophy does not appear to mediate the diabetes-cognition relationship.
The American College of Cardiology published an expert consensus statement regarding decision considerations for novel cardiovascular risk reduction therapies in patients with type 2 diabetes and atherosclerotic cardiovascular disease.
Approximately 50% of deaths in people with type 2 diabetes worldwide, and approximately two-thirds of deaths in people with type 2 diabetes in the US are caused by cardiovascular disease.
The American Diabetes Association issued a position statement outlining the recognition, management, and prevention of T2D in the pediatric population.
Patients with both Parkinson disease and type 2 diabetes were more likely to have cardiovascular comorbidities than those with only Parkinson disease.
Access to ready-to-eat outlets that sell food for instant consumption is associated with greater risk for type 2 diabetes.